| 000 | 01665 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517212756.0 | ||
| 264 | 0 | _c20190603 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a2169-141X | ||
| 024 | 7 |
_a10.1080/21691401.2018.1463231 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, Ting-Ting | |
| 245 | 0 | 0 |
_aCyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system. _h[electronic resource] |
| 260 |
_bArtificial cells, nanomedicine, and biotechnology _c2018 |
||
| 300 |
_a552-564 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aChitosan _xchemistry |
| 650 | 0 | 4 |
_aCyclosporine _xchemistry |
| 650 | 0 | 4 |
_aDrug Carriers _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aInterleukin-4 _xmetabolism |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
| 650 | 0 | 4 |
_aLeukocytes _xcytology |
| 650 | 0 | 4 |
_aLung _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaterials Testing |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPorosity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aWen, Bao-Fang | |
| 700 | 1 | _aLiu, Kang | |
| 700 | 1 | _aQin, Meng | |
| 700 | 1 | _aGao, Yuan-Yuan | |
| 700 | 1 | _aDing, De-Jun | |
| 700 | 1 | _aLi, Wen-Tong | |
| 700 | 1 | _aZhang, Yun-Xiang | |
| 700 | 1 | _aZhang, Wei-Fen | |
| 773 | 0 |
_tArtificial cells, nanomedicine, and biotechnology _gvol. 46 _gno. sup2 _gp. 552-564 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/21691401.2018.1463231 _zAvailable from publisher's website |
| 999 |
_c28319402 _d28319402 |
||